Bruls Annette
CVP, EMEACLA
Bruls Annette has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Aug 28, 2026.
On the most recent filing, Bruls Annette is listed as CVP, EMEACLA at Edwards Lifesciences Corp. Inside the rolling window, Bruls Annette reported no open-market purchases and 1 open-market sale totaling $238K in EW.
Companies traded
Other insiders at EW
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$238K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Bruls Annette made?
Bruls Annette has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company since 2026.
Which companies does Bruls Annette trade?
Bruls Annette has filed SEC Form 4 disclosures for 1 company, including EW.
When was Bruls Annette's most recent SEC Form 4 filing?
Bruls Annette's most recent SEC Form 4 filing on Tracefour is dated Aug 28, 2026.
What is Bruls Annette's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Bruls Annette is listed as CVP, EMEACLA.
What is Bruls Annette's total buy and sell value in the current window?
Inside the rolling retention window, Bruls Annette bought $0 and sold $238K based on SEC Form 4 filings.
What was Bruls Annette's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 2,644 EW shares on 2026-08-28, worth $238K, per SEC Form 4 filings.